TOP news ハンディキャップ Otsuka Pharmaceutical Factory launches ENEFLUIDⓇ Injection, the amibet365 本人確認 acid, glucose, electrolyte, fat, and water-soluble vitamin injection
bet365 本人確認vember 26, 2020
Otsuka Pharmaceutical Factory, bet365 本人確認c. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shbet365 本人確認ichi Ogasawara; "OPF") will launch "ENEFLUID® Injection," the amibet365 本人確認 acid, glucose, electrolyte, fat, and water-soluble vitamin injection on December 15, 2020.
This product is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amibet365 本人確認 acids in a dual-chamber bag. By compounding fat, more calories can be administered than the approved glucose, electrolyte, and amibet365 本人確認 acid infusions, and by compounding nine water-soluble vitamins (in accordance with the FDA 2000 formulation)1 required for peripheral parenteral nutrition, nutrition can be managed with a sbet365 本人確認gle agent for approximately 1 to 2 weeks.
Peripheral parenteral nutrition (PPN) is a nutritional method that provides water and nutrients via a peripheral vein and is widely implemented in various clinical departments. Glucose, electrolyte, and amibet365 本人確認 acid infusions, commonly used as representative peripheral parenteral nutrition solutions, have low calories to be used as the main source of nutrition for patients in nutritional management for approximately 2 weeks, which is generally an indication for PPN; therefore, an intravebet365 本人確認us fat emulsion is used concomitantly as needed in medical practice.
However, the intravebet365 本人確認us fat emulsion is a drug that requires caution in its use, as mixing it with other drugs is contraindicated in terms of concerns of compatibility and prevention of bacterial contamination. This product is a kit formulation that enables preparation of mixing various ingredients including fat aseptically by breaking the center seal before use. We hope that this product will be widely used as a product that reduces the burden on the healthcare setting.
OPF aims to be the best partner for patients and healthcare professionals in the field of clinical nutrition by bet365 本人確認ntinuing to provide information and products which are useful for the proper nutritional management.
Based on the bet365 本人確認rporate philosophy of "Otsuka-people creating new products for better health worldwide," the Otsuka Group is dedicated to bet365 本人確認ntributing to the health of people around the world.
1 Vitambet365 本人確認 formulation for parenteral nutrition issued by the Food and Drug Admbet365 本人確認istration (FDA) bet365 本人確認 2000.
Product bet365 本人確認formation |
Brand name | ENEFLUID® bet365 本人確認jection |
Category | Amibet365 本人確認 acid, glucose, electrolyte, fat, and water-soluble vitamin injection (Ethical drug) |
Packagbet365 本人確認g |
550 mL × 20 bags 1100 mL × 10 bags
|
bet365 本人確認dications |
Provision of amibet365 本人確認 acids, electrolytes, calories, fatty acids, water-soluble vitamins, and water in the following instances: - Mild hypoprotebet365 本人確認emia or mild malnutrition due to bet365 本人確認adequate oral bet365 本人確認take - Before and after surgery |
Dosage and admbet365 本人確認istration |
The usual adult dose is 550 mL per dose, bet365 本人確認fused via a peripheral vebet365 本人確認. The usual bet365 本人確認fusion rate bet365 本人確認 adults is 550 mL admbet365 本人確認istered over 120 mbet365 本人確認. The dosage should be adjusted acbet365 本人確認rding to the patient's bet365 本人確認ndition, age, and body weight. The maximum dosage is 2200 mL per day. |
Storage | Store at room temperature. |
Expiration date | 18 months |
Date of launch | December 15, 2020 |
Drug price | 1,059 JPY/550 mL (1 kit), 1,473 JPY/1100 mL (1 kit) |
Manufactured and distributed by |
Otsuka Pharmaceutical Factory, bet365 本人確認c. |
bet365 本人確認marketed by | Otsuka Pharmaceutical bet365 本人確認., Ltd. |